Series (2018) - Trends and Challenges in Liver Transplantation

TTS New Webinar Series

EC Liver Series v2

The Education Committee of TTS will be organizing six new webinars on the "trends and Challenges in Liver Transplantation". The series, organized by Sukru Emre, will host the first webinar on January 19. See details below.

Confirmed Webinars

  • Click here to view the recording (you must be logged into the website)

    TTS Education Committee Webinar Series "Trends and Challenges in Liver Transplantation"
    TOPIC: PSC/PBC and AIH
    TITLE: Autoimmune Liver Disease 360º
    Thursday, April 19, 2018 - 3:00 pm DST (Montreal time)

    sukru Organizer/Moderator: Professor Sukru Emre, MD
    Professor of Surgery (Transplant) and of Pediatrics, Yale University, USA
    David Assis Discussant: David Assis, MD
    Assistant Professor of Medicine (Digestive Diseases)
    Yale School of Medicine New Haven, CT, USA
    Julie Heimbach Discussant: Julie Heimbach, MD
    Transplant Surgeon and Surgical Director of Liver Transplantation
    Mayo Clinic, Rochester, MN, USA


    David Assis Biography:

    Dr. David N. Assis is a hepatologist and assistant professor of medicine at Yale University School of Medicine. His training in liver diseases, including research fellowship and transplant hepatology, took place at Yale. He now focuses on autoimmune liver diseases in his clinical practice and also performs NIH-funded translational research to better understand the mechanisms of Autoimmune Hepatitis, Primary Biliary Cholangitis and Primary Sclerosing Cholangitis, and to develop new immune-based therapies for treatment of these disorders.

    Julie K. Heimbach Biography:

    Julie K. Heimbach, M.D., is a Professor of Surgery and the Chair of the Division of Transplantation Surgery at Mayo Clinic in Rochester, Minnesota. She is currently a member of the Governing Board of the American Association for the Study of Liver Disease; chair of the Communications Committee of the American Society of Transplant Surgeons; and chair of the Liver and Intestinal Transplant Committee of the OPTN/UNOS, the national organization charged with oversight of organ transplantation in the United States. She also serves as associate editor of the American Journal of Transplantation. Dr. Heimbach’s research focuses on living donor transplantation, obesity and transplantation, and liver transplantation for hilar cholangiocarcinoma.


  • Click here to view the recording (you must be logged into the website)

    TTS Education Committee Webinar Series "Trends and Challenges in Liver Transplantation"
    Challenging Problems in Pediatric Liver Transplantation: Long Term Allograft Attrition
    Wednesday, March 28, 2018 - 2pm EST (Montreal)

    sukru Organizer/Moderator: Professor Sukru Emre, MD
    Professor of Surgery (Transplant) and of Pediatrics, Yale University, USA
    Esquivel Discussant: Carlos O. Esquivel, MD, PhD
    Arnold and Barbara Silverman Professor in Pediatric Transplantation,
    Stanford University School of Medicine, Stanford, CA, USA
    Horslen Discussant: Simon P. Horslen, MB ChB
    Director of the Hepatobiliary and Intestinal Failure programs
    Medical Director for Solid Organ Transplantation, Seattle Childrens Hospital, USA


    Overview:

    Dr. Simon Horslen would like to make the case that the most difficult and yet the most important problem we face in Pediatric Liver transplantation is long term allograft health. While short term outcomes have improved dramatically, the long-term rate of graft fibrosis and graft loss has really not changed, and because of the age of pediatric patients at the time of transplant most of the morbidity falls on the adolescents and young adults.


    Carlos O. Esquivel Biography:

    Carlos O. Esquivel is Professor of Surgery at Stanford University School of Medicine, Chief of the Division of Abdominal Transplantation and the Associate Director of the Institute of Immunity, Transplantation and Infection, an umbrella institute that fosters interdisciplinary research between basic scientists and clinicians. Dr. Esquivel is the first recipient of the Arnold and Barbara Silverman Professorship in Transplantation. He received his M.D. degree from the University of Costa Rica School of Medicine, completed general surgery training at the University of California Davis and then obtained a doctoral degree from the University of Lund in Sweden. He trained in transplantation of the liver, kidney, pancreas and intestine at the University of Pittsburgh under the direction of Dr. Thomas Starzl. In 1995, he was recruited to Stanford to start the Pediatric Transplant Programs at LPCH and rebuild the Adult Liver and Kidney Transplant Program.

    Dr. Esquivel is recognized worldwide as an expert and pioneer in transplantation. He is a creative and productive investigator having contributed 338 publications in the medical literature and given over 200 lectures throughout the United States and internationally. He oversees multiple basic science and clinical research projects and is currently PI for a 5-year, multi-center NIH grant to develop biomarkers for Epstein-Barr Virus-induced post-transplant lymphomas in children. As a transplant leader at Stanford and in key national and international societies, he promotes team cooperation, embraces change and creates an environment for fostering discovery, and for training leaders of the future. In recognition of his many contributions to surgical education, Dr. Esquivel received the American Society of Transplant Surgeons 2015 Francis Moore Excellence in Mentorship in the Field of Transplantation Award.

    Simon Horslen Biography:

    Simon Horslen MB ChB FRCPCH FAST FAASLD is a Professor in the Division of Pediatric Gastroenterology, Hepatology & Nutrition at Seattle Children’s Hospital and the University Of Washington School Of Medicine. He is Medical Director for Solid Organ Transplantation at Seattle Children’s Hospital. Dr. Horslen earned his medical degree at the University Of Bristol, England and is a Fellow and Founder Member of the Royal College of Paediatrics and Child Health.

    He has worked in the US for the last 20 years initially at the University Of Nebraska Medical Center and currently in Seattle. He is a Pediatric Hepatologist and Transplant Physician with many years’ experience of liver and intestinal transplantation in children. Dr Horslen participates in several multicenter research studies including SPLIT (Studies in Pediatric Liver Transplantation), PALF (Pediatric Acute Liver Failure) and ChiLDREN (Children’s Liver Disease Research Network). Dr Horslen is a past-Chair of the UNOS/OPTN Pediatric Committee and of the Pediatric Community of Practice of the American Society of Transplantation (AST). He is current Chair of SPLIT (Studies of Pediatric Liver Transplantation) and President Elect of IRTA (Intestinal Rehabilitation and Transplantation Association).


  • Date and time: January 19th, 2018 2:00 PM EST (UTC-5 hours)
    Topic: Antibody Mediated Rejection in Liver Transplantation Part I - Role of DSA's and Treatment Options
    Description: Antibody mediated rejection (AMR) has become one of the hot topics in liver transplantation recently. In this webinar, world known experts in this topic will discuss the immunological, clinical aspects of AMR as well as available treatment options.
    Format: Debate/Discussion

    Click here to view the recording (you must be logged into the website)

    sukru Organizer: Professor Sukru Emre, MD
    Professor of Surgery (Transplant) and of Pediatrics, Yale University, USA
    Udeme Ekong Moderator: Udeme D Ekong, MD, MPH
    Associate Professor of Pediatrics (Gastroenterology), Yale University, USA

    wozniak Discussant: Laura J. Wozniak, MD, MS
    Associate Clinical Professor, Department of Pediatrics, Division of Gastroenterology, Hepatology, and Nutrition at UCLA, USA
    oleary Discussant: Jacqueline O'Leary, MD, MPH
    Medical Director of Research for the Baylor Simmons TransplantInstitute in Dallas, Texas, USA

Our Corporate Sponsors

TTS gratefully acknowledges the Corporate Partners whose generous support makes the work of the Society possible:

  • astellas
  • roche
  • sanofi